PKAcalpha, actif, humain étiqueté GST, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9, >= 70% (SDS-PAGE), solution aqueuse tamponnée de glycérol

Code: k3019-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Protein kinase A (PKA) is a mediator of cAMP (cyclic adenosine monophosphate) and contains two regulatory and two catalytic subunits. Mutations in PRK...


en savoir plus

Votre prix
$542.10 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Protein kinase A (PKA) is a mediator of cAMP (cyclic adenosine monophosphate) and contains two regulatory and two catalytic subunits. Mutations in PRKACA (protein kinase cAMP-activated catalytic subunit α) are associated with Cushing′s syndrome. PRKACA encodes two splice variants, Cα1 and Cα2. Cα1 is widely expressed and Cα2 is restricted to the sperm cells.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, with 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... PRKACA(5566)
mol wt~69 kDa
product linePRECISIO® Kinase
Quality Level200
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity1626-2201 nmol/min·mg
storage temp.−70°C
UniProt accession no.P17612
Ce produit répond aux critères suivants: